Xanthopoulos Kleanthis Gabriel — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Xanthopoulos Kleanthis Gabriel has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Kleanthis Gabriel Xanthopoulos is a director at Connect Biopharma Holdings Ltd, a biopharmaceutical company focused on developing innovative therapies for patients with autoimmune diseases. He has a background in the pharmaceutical and biotechnology sectors, contributing to various strategic roles in drug development and corporate governance.
Role
Director
Notability
70/100
Board memberships
Connect Biopharma Holdings Ltd
Awards & honors
Director at Connect Biopharma Holdings Ltd
Experience in pharmaceutical and biotechnology sectors
Kleanthis Gabriel Xanthopoulos is a director at Connect Biopharma Holdings Ltd, a biopharmaceutical company focused on developing innovative therapies for patients with autoimmune diseases. He has a background in the pharmaceutical and biotechnology sectors, contributing to various strategic roles in drug development and corporate governance.…
How many SEC Form 4 filings has Xanthopoulos Kleanthis Gabriel submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Xanthopoulos Kleanthis Gabriel's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
